S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Published Date: 28 Aug 2026

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

Read Full News

Latest News

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

What's Driving Pancreatic Cancer Risk?

From modifiable habits to genetic red flags, here's what raises pancreatic cancer risk, and when to screen for it.

Rapid Genetic Screening May Protect Newborn Hearing

A rapid bedside genetic test may help neonatologists avoid gentamicin-related hearing loss in newborns at the highest risk.

Early Breast Cancer: Time to Act on Molecular Resistance?

In breast cancer, molecular resistance can precede clinical progression, but should it prompt an immediate change in treatment?

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

From modifiable habits to genetic red flags, here's what raises pancreatic cancer risk, and when to screen for it.

A rapid bedside genetic test may help neonatologists avoid gentamicin-related hearing loss in newborns at the highest risk.

In breast cancer, molecular resistance can precede clinical progression, but should it prompt an immediate change in treatment?

News All Time

S3 Episode 6: Epidemiology of Endometrial Cancer

Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors.

Game Changers: Navigating Zongertinib’s Role in HER2+ NSCLC

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

Spotting Seborrheic Keratosis vs Melanoma in Primary Care

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

Beyond Water and Oxalate: New Era in Kidney Stone Prevention

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Lyme Disease 101: Stages, Testing, and Prevention

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

Excess and Dysfunctional Fat as a Primary Driver of HFpEF

The role of excess and dysfunctional fat in the genesis of HFpEF is well recognized, likely representing a primary or major upstream contributing cause in the large majority of patients.

Primary or Substance-Induced Psychosis? How to Tell and Treat

Distinguishing substance-induced psychosis from primary psychotic disorders starts with the history. Dr Adjoa Smalls-Mantey reviews the diagnostic clues and treatment approach.

S1 Episode 6: Choosing Therapies for ATTR-CM in 2026

Drs Alexander and Urey walk through stabilizers vs silencers, pivotal trial data, and practical first line choices to help you select the right ATTR CM therapy for each patient.

Melanoma Clues Every PCP Should Know

A mole that stands out from the rest or keeps changing may be a warning sign. See how PCPs can use the ugly duckling sign and other clues in melanoma assessment.

Woman Develops Autoimmune/Inflammatory Syndrome After Filler

A woman develops autoimmune/inflammatory syndrome induced by adjuvants after hyaluronic acid filler and hyaluronidase exposure, with biopsy-confirmed acquired cutis laxa.

S1 Episode 3: Incidental Fatty Liver on Imaging: What Should You Do Next?

When fatty liver appears incidentally on imaging, "just lose weight" isn't enough. Dr Brandman explains how to use FIB-4, FibroScan, and ELF to triage who needs referral and who doesn't.

When to Worry About Pediatric Joint Pain

Which pediatric musculoskeletal complaints need an urgent workup? Dr Basco shares a systematic approach to identifying clinical red flags and serious pathology.

Fast Five Quiz: Presentation and Diagnosis of Psoriasis

How much do you know about the presentation and diagnosis of psoriasis? Test your knowledge with this quick quiz.

Skin Biopsy Essentials for Primary Care

Selecting the right biopsy technique is key to accurate diagnosis. Review practical guidance on shave and punch biopsies in primary care.

Pott’s Puffy Tumor in Teen Leads to Bilateral Blindness

A teen with Pott’s puffy tumor develops irreversible bilateral blindness after delayed diagnosis and intracranial complications, highlighting the importance of its early recognition.

Anti-Amyloids and Meaningful Change

Preventive neurologists Richard Isaacson and Jennifer Buczyner discuss the role of anti-amyloid drugs in patients with Alzheimer’s or mild cognitive impairment.

Recommended News For You

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Breast Cancer Incidence Rises in Asian American Women

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

Alcohol Causes Cancer. We Should Be Drinking Less.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

Recommended Articles For You

Managing Delayed Toxicities of Targeted Anticancer Therapies 

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy 

Unraveling the Genetic Mystery of Hereditary Spherocytosis 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

10-year study shows tomosynthesis improves breast cancer detection

2.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

3.

Microplastics can cause malignant changes in lung cells

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Two medications might work better for breast cancers that are resistant to one.

1.

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment

2.

Digital Morphology Libraries for Hematology Education: Transforming Diagnostic Training and Clinical Practice

3.

Iron Metabolism and Inflammatory Disorders: Mechanisms, Clinical Implications, and Therapeutic Approaches

4.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

5.

Tumor Microenvironment Readiness as a Predictor of Cancer Progression

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

4.

Nutrition During Cancer Treatment

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot